Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 244

The DOI matches its Crossref record.

A Comparison of Itraconazole Versus Fluconazole as Maintenance Therapy for AIDS‐Associated Cryptococcal Meningitis

Saag, Michael S., Cloud, Gretchen A., Graybill, J. Richard, Sobel, Jack D., Tuazon, Carmelita U., Johnson, Philip C., Fessel, W. Jeffrey, Moskovitz, Bruce L., Wiesinger, Barbara, Cosmatos, Dennis, Riser, Laura, Thomas, Carolynn, Hafner, Richard, Dismukes, William E., the National Institute of Allergy and Infectious Diseases Mycoses Study Group·1999·Clinical Infectious Diseases

Abstract

This study was designed to compare the effectiveness of fluconazole vs. itraconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. HIV-infected patients who had been successfully treated (achieved negative culture of CSF) for a first episode of cryptococcal meningitis were randomized to receive fluconazole or itraconazole, both at 200 mg/d, for 12 months. The study was stopped prematurely on the recommendation of an independent Data Safety and Monitoring Board. At the time, 13 (23%) of 57 itraconazole recipients had experienced culture-positive relapse, compared with 2 relapses (4%) noted among 51 fluconazole recipients (P = .006). The factor best associated with relapse was the patient having not received flucytosine during the initial 2 weeks of primary treatment for cryptococcal disease (relative risk = 5.88; 95% confidence interval, 1.27-27.14; P = .04). Fluconazole remains the treatment of choice for maintenance therapy for AIDS-associated cryptococcal disease. Flucytosine may contribute to the prevention of relapse if used during the first 2 weeks of primary therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/515110

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 244

Metadata

Authors
Saag, M. S., Cloud, G. A., Graybill, J. R., Sobel, J. D., Tuazon, C. U., Johnson, P. C., Fessel, W. J., Moskovitz, B. L., Wiesinger, B., Cosmatos, D., Riser, L., Thomas, C., Hafner, R., Dismukes, W. E., & the National Institute of Allergy and Infectious Diseases Mycoses Study Group
Venue
Clinical Infectious Diseases
Published
1999-02
Volume
28
Issue
2
Pages
291-296
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2139861350
Cited by
244
References
0
FWCI
10.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Comparison of Itraconazole Versus Fluconazole as Maintenance Therapy for AIDS‐Associated Cryptococcal Meningitis. https://app.cochat.ai/papers/10.1086/515110
The paper
Saag, M. S., Cloud, G. A., Graybill, J. R., Sobel, J. D., Tuazon, C. U., Johnson, P. C., Fessel, W. J., Moskovitz, B. L., Wiesinger, B., Cosmatos, D., Riser, L., Thomas, C., Hafner, R., Dismukes, W. E., & the National Institute of Allergy and Infectious Diseases Mycoses Study Group. (1999). A Comparison of Itraconazole Versus Fluconazole as Maintenance Therapy for AIDS‐Associated Cryptococcal Meningitis. Clinical Infectious Diseases. https://doi.org/10.1086/515110

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.